An 11-year-old boy has a linear scleroderma lesion extending over his knee joint, causing a flexion contracture. You decide to initiate systemic therapy for this deep, function-limiting lesion. According to consensus treatment plans for juvenile localized scleroderma, which combination therapy is considered a first-line, effective regimen?